Moreover, METTL3 has been highlighted to augment the m6A modification in 3’-untranslated region (3'-UTR) of CUB domain containing protein 1 (CDCP1) mRNA, which is positively correlated with the malignancy status of bladder cancer [17]. Here, METTL3 is linked to urinary bladder cancer.